TAGS "Samsung Bioepis"
All News Samsung Bioepis In Focus Samsung Bioepis BreakingNews of Samsung Bioepis Your Interested Follow Story Samsung Bioepis
Samsung Bioepis, Merck & Co. launch Remicade biosimilar in US
Samsung Bioepis, Merck & Co. launch Remicade biosimilar in US
TUESDAY, JULY 25, 2017
SEOUL - South Korean biopharmaceutical firm Samsung Bioepis Co. said Tuesday that its biosimilar drug Renflexis was launched in the United States following the approval of the US Food and Drug Administration.